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Background: We have proposed stent axial recoil at lesions after drug-eluting stent (DES) implantation, especially at stent fracture (SF) lesions 
and named it stent recoil (SR). We evaluated the incidence, risk factors, and clinical impacts of SR.
methods and results: SR was defined as axial recoil less than 80% in stent diameter. SF was defined as the separation of stent segments or 
stent struts. The study population consisted of 11617 lesions (5068 patients) that were treated exclusively with DES from 2003 to 2012. Follow-up 
angiography was performed within one year after index procedure. SF was observed in 494 lesions (4.3%) and SR with SF in 138 lesions (1.2%). 
Independent positive predictors of SR with SF were calcification, ostial stent implantation in the right coronary artery, and in-stent restenosis lesion. 
A negative one was biolimus-eluting stent implantation. According to the Kaplan-Meier methods and log-rank test, the rates of any target lesion 
revascularization (TLR), clinically driven TLR, and even all-cause death were significantly higher in the SR with SF group than in the non-SR with SF 
group (log-rank p≤0.001, <0.001 and =0.01, respectively). The mean follow-up duration was 1600 days (interquartile range 763 to 1825 days).
conclusion: The incidence of SR with SF after DES implantation could be related to both lesion characteristics and DES type. SR with SF appears 
to be associated with not only TLR but also other clinical events as compared with non-SR with SF.
